Biotech

All Articles

Biogen cans SAGE-324 cooperation after vital trembling fall short

.Biogen has carried out the final rites to its cooperation along with Sage Rehabs on SAGE-324, ditch...

AbbVie Parkinson's drug from $8.7 B Cerevel acquistion credit ratings

.On the same time that some Parkinson's ailment medications are actually being questioned, AbbVie ha...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arch Venture Partners is proving...

Orion to use Aitia's 'digital doubles' to locate brand-new cancer cells medications

.Finnish biotech Orion has spied potential in Aitia's "digital twin" technology to create brand-new ...

Windtree's surprise med brings up blood pressure in most recent period 2 win

.While Windtree Rehabs has strained to expand the monetary origins required to endure, a period 2 su...

2 cancer biotechs combine, producing international impact

.OncoC4 is taking AcroImmune-- and its own internal medical manufacturing capacities-- under its win...

Amgen reports 1st stage 3 win for $400M chronic eczema medicine

.Amgen has shared (PDF) the very first period 3 information on its own $400 thousand dermatitis medi...

Biogen, UCB file period 3 lupus win after falling short earlier trial

.Biogen as well as UCB's bank on developing into phase 3 on the back of a broken research hopes to h...

Aptadir wishes brand new RNA inhibitors can easily reverse challenging cancers cells

.Italian biotech Aptadir Therapeutics has launched along with the commitment that its own pipe of pr...

Wave surfs DMD effectiveness to regulators' doors, sending stockpile

.Wave Lifestyle Sciences has actually met its own objective in a Duchenne muscular dystrophy (DMD) s...